Spain· ES:74097
CÁSCARA SAGRADA ARKOPHARMA CÁPSULAS DURAS
A cascara product containing rhamnus purshianus, registered in Spain by Arkopharma Laboratorios S.A.U.. The same ATC class is registered in 2 of our 19 countries.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
Where it is registered
Cascara is registered in 2 of 19 countries.
Countries holding a registration under ATC A06AB07 (cascara), each read from that country’s own register.
- This record: Spain, from AEMPS CIMA (Spain)
- 1 of them publish a price we can compare per daily dose
Cascara · ATC A06AB07
2 / 19 countries
- Japan
- Spainprice
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- Rhamnus Purshianus
- Manufacturer
- Arkopharma Laboratorios S.A.U.
- Country
- Spain (ES)
- ATC code
- A06AB07
- ATC class
- Cascara
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- August 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under A06AB07
Cascara, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/385cb87e-a22d-4f8a-8419-b91a7a2e1f59 GET /v1/drugs/385cb87e-a22d-4f8a-8419-b91a7a2e1f59?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Sin Receta",
"estado": "{\"aut\":1306101600000}",
"nregistro": "74097",
"substance": "Rhamnus Purshianus"
}See everything about cascara.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.